Your browser doesn't support javascript.
loading
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.
Serrano, A; Márquez, A; Mackie, S L; Carmona, F D; Solans, R; Miranda-Filloy, J A; Hernández-Rodríguez, J; Cid, M C; Castañeda, S; Morado, I C; Narváez, J; Blanco, R; Sopeña, B; García-Villanueva, M J; Monfort, J; Ortego-Centeno, N; Unzurrunzaga, A; Marí-Alfonso, B; Sánchez Martín, J; de Miguel, E; Magro, C; Raya, E; Braun, N; Latus, J; Molberg, O; Lie, B A; Moosig, F; Witte, T; Morgan, A W; González-Gay, M A; Martín, J.
Afiliação
  • Serrano A; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
  • Márquez A; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
  • Mackie SL; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, West Yorkshire, UK.
  • Carmona FD; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
  • Solans R; Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain.
  • Miranda-Filloy JA; Department of Rheumatology, Hospital Xeral-Calde, Lugo, Spain.
  • Hernández-Rodríguez J; Vasculitis Research Unit, Department of Autoimmune and Systemic Diseases, Hospital Clinic, University of Barcelona, Centre de Recerca Biomèdica Cellex (IDIBAPS), Barcelona, Spain.
  • Cid MC; Vasculitis Research Unit, Department of Autoimmune and Systemic Diseases, Hospital Clinic, University of Barcelona, Centre de Recerca Biomèdica Cellex (IDIBAPS), Barcelona, Spain.
  • Castañeda S; Department of Rheumatology, Hospital de la Princesa, IIS-Princesa, Madrid, Spain.
  • Morado IC; Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain.
  • Narváez J; Department of Rheumatology, Hospital Universitario de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Blanco R; Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain.
  • Sopeña B; Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Spain.
  • García-Villanueva MJ; Department of Rheumatology, Hospital Ramón y Cajal, Madrid, Spain.
  • Monfort J; Department of Rheumatology, Grup de recerca cellular en inflamació i cartílag. IMIM (Institut de Recerca Hospital del Mar), Barcelona, Spain.
  • Ortego-Centeno N; Department of Internal Medicine, Hospital Clínico San Cecilio, Granada, Spain.
  • Unzurrunzaga A; Department of Internal Medicine, Hospital de Galdakano, Vizcaya, Spain.
  • Marí-Alfonso B; Department of Internal Medicine, Corporació Sanitaria Parc Taulí, Instituto Universitario Parc Taulí, UAB, Sabadell, Barcelona, Spain.
  • Sánchez Martín J; Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid.
  • de Miguel E; Department of Rheumatology, Hospital Universitario de La Paz, Madrid, Spain.
  • Magro C; Department of Rheumatology, Hospital Clínico Universitario San Cecilio, Granada.
  • Raya E; Department of Rheumatology, Hospital Clínico Universitario San Cecilio, Granada.
  • Braun N; Department of Internal Medicine, Division of Nephrology, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Latus J; Department of Internal Medicine, Division of Nephrology, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Molberg O; Department of Rheumatology, Oslo University Hospital, Oslo, Norway and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Lie BA; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Moosig F; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Witte T; Department of Clinical Immunology and Rheumatology, University of Luebeck, Bad Bramstedt, Germany.
  • Morgan AW; Hannover Medical School, Hannover, Germany.
  • González-Gay MA; NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, West Yorkshire, UK.
  • Martín J; Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain.
Ann Rheum Dis ; 72(11): 1882-1886, 2013 Nov.
Article em En | MEDLINE | ID: mdl-23946333
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arterite de Células Gigantes / Quinases da Família src / Proteína Tirosina Fosfatase não Receptora Tipo 22 Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arterite de Células Gigantes / Quinases da Família src / Proteína Tirosina Fosfatase não Receptora Tipo 22 Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Espanha